Alan B. Frey

9.5k citations
88 papers · 7.4k indexed · 1 hit paper · h-index 38

Alan B. Frey

86 papers receiving 7.3k citations

Hit Papers

Recommendations for myeloid-derived suppressor cell nomen...2.0k201620262019202250010001.5k2.0k

Peers

Alan B. Frey
Comparison fields: 5 of 124
  • Immunology 4.3k
  • Oncology 2.2k
  • Developmental Neuroscience 225
  • Neurology 282
  • Molecular Biology 2.2k
Replace Seiji Okada with:
Seiji Okada Japan
Barbara A. Osborne United States
David Kägi Switzerland
Paul Conlon United States
Patrick W. Gray United States
Ivan D. Horak United States
Maureen Howard United States
Xiaojing Ma United States
Tak W. Mak Canada
Christopher P. Dillon United States
Alan B. Frey relative to Seiji Okada Japan Seiji Okada's profile →
Citations per field
00.5×1.5×1.8×
Seiji Okada · 1×
Citations per year

Countries citing papers authored by Alan B. Frey

Since Specialization
Citations

This map shows the geographic impact of Alan B. Frey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan B. Frey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan B. Frey more than expected).

Fields of papers citing papers by Alan B. Frey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan B. Frey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan B. Frey. The network helps show where Alan B. Frey may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Alan B. Frey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alan B. Frey Line = papers co-authored together Alan B. Frey links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20172
2 201616
3
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standardsbreakdown →
20162010
4 2012231
5 201150
6 200756
7 200628
8 200561
9 200211
10 200149
11 2001130
12 2001128
13 2000175
14 200069
15 19998
16
Repression of IL-2 mRNA translation in primary human breast cancer tumor infiltrating lymphocytes
19981
17 19987
18 199716
19 199534
20 199154

About Alan B. Frey

Alan B. Frey is a scholar working on Immunology, Parasitology, Oncology, Pharmacology and Infectious Diseases, having authored 88 papers that have together received 7.4k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (38 papers), Immunotherapy and Immune Responses (33 papers), T-cell and B-cell Immunology (27 papers), Cancer Immunotherapy and Biomarkers (11 papers), Virus-based gene therapy research (7 papers), Immune cells in cancer (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and CAR-T cell therapy research (6 papers). The work is most often cited by research in Immunology (4.3k citations), Oncology (2.2k citations), Developmental Neuroscience (225 citations), Neurology (282 citations) and Molecular Biology (2.2k citations). Alan B. Frey has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Gert Kreibich, Ngozi Monu, Marian R. Neutra, Augusto C. Ochoa, Jean-Pierre Kraehenbühl, David D. Sabatini, Paulo C. Rodrı́guez, Dmitry I. Gabrilovich, Suzanne Ostrand‐Rosenberg and Shu‐Hsia Chen. Their work appears in journals such as The Journal of Immunology, Cellular Immunology, Molecular and Cellular Biology, Journal of Leukocyte Biology and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026